SLILATY STEVE N. (Chief Executive Officer) received a stock award from SUNSHINE BIOPHARMA INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 7/10/2020ACC: 0001128732-20-000003
DirectorOfficer· Chief Executive Officer
Since Aug 2018
+2.72M
Net shares
Net buyer
$2.7K
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
2.72M acquired
Non-Derivative Transactions3
Common Stock
Direct
Shares
+1.10M
Price / share
$0.00
Trade value
$1.10K
% of position
116.6%
10/20/2019
943.46K→2.04M
Common Stock
Direct
Shares
+1.30M
Price / share
$0.00
Trade value
$1.30K
% of position
63.6%
12/19/2019
2.04M→3.34M
Common Stock
Indirect
Shares
+323.67K
Price / share
$0.00
Trade value
$323.67
% of position
60.2%
12/31/2019
537.54K→861.21K
Total
Net shares
+2.72M
Net value
$2.72K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/20/2019 | A · Award | +1.10M | $0.00 | $1.10K | 116.6% | 943.46K | 2.04M |
| Common Stock Direct | 12/19/2019 | A · Award | +1.30M | $0.00 | $1.30K | 63.6% | 2.04M | 3.34M |
| Common Stock Indirect | 12/31/2019 | J · J | +323.67K | $0.00 | $323.67 | 60.2% | 537.54K | 861.21K |
| Total | +2.72M | $2.72K | ||||||
Derivative Transactions0
No derivative transactions reported